Investigation and Research on Antiplatelet Therapy Adherence in Patients after 1 Year of Percutaneous Coronary Intervention

王慧丽,杨渊,丁荣晶,杜娟,胡大一
2014-01-01
Abstract:Objective To investigate the adherence of antiplatelet therapy and its influence on clinical outcomes in patients after 1 year of percutaneous coronary intervention( PCI). Methods The follow-up was performed in 1 203 patients undergoing PCI for the first time in Peking University People's Hospital from January 1,2006 to December 31, 2009,including the adherence of antiplatelet,related factors and major adverse cardiac events. Results After 1 year of PCI,49. 8% patients maintained adherence and 8. 4% patients quitted antiplatelet therapy totally. The main reasons were that patients thought it was not necessary to take medicine and feared the side effects. Age( OR = 1. 027,95% CI: 1. 005-1. 048),educational level( OR = 4. 206,95% CI: 1. 064-16. 625) and number of concomitant diseases( OR = 0. 653,95% CI: 0. 450-0. 947) could affect the adherence of antiplatelet therapy. No significant correlation was noted between antiplatelet therapy and the incidence of MACE( OR = 0. 203,95% CI: 0. 117-0. 354). Conclusions The adherence of antiplatelet therapy in patients after 1 year of PCI is not satisfactory. No antiplatelet therapy is one of the risk factors of MACE after 1 year of PCI.
What problem does this paper attempt to address?